WEXCARE PHARMACEUTICAL PVT LTD
⚠️ High Risk
FEI: 3024634352 • Mehsana • INDIA
FEI Number
3024634352
Location
Mehsana
Country
INDIAAddress
S-220 Icon Arcade Radha, , Mehsana, , India
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
Frequently Asked Questions
What is WEXCARE PHARMACEUTICAL PVT LTD's FDA import refusal history?
WEXCARE PHARMACEUTICAL PVT LTD (FEI: 3024634352) has 2 FDA import refusal record(s) in our database, spanning from 11/13/2025 to 11/13/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. WEXCARE PHARMACEUTICAL PVT LTD's FEI number is 3024634352.
What types of violations has WEXCARE PHARMACEUTICAL PVT LTD received?
WEXCARE PHARMACEUTICAL PVT LTD has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about WEXCARE PHARMACEUTICAL PVT LTD come from?
All FDA import refusal data for WEXCARE PHARMACEUTICAL PVT LTD is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.